Advertisement

Topics

Friday preview: All attention on AstraZeneca and Hikma numbers

11:17 EDT 17 May 2018 | FinanzNachrichten

After three packed days of company news, London's diary for Friday is much lighter, with quarterly numbers from drug makers AstraZeneca and Hikma getting the full attention of investors. Since the ...

Original Article: Friday preview: All attention on AstraZeneca and Hikma numbers

NEXT ARTICLE

More From BioPortfolio on "Friday preview: All attention on AstraZeneca and Hikma numbers"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...